These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35068929)

  • 1. Beyond Dual Bronchodilation - Triple Therapy, When and Why.
    Cazzola M; Rogliani P; Laitano R; Calzetta L; Matera MG
    Int J Chron Obstruct Pulmon Dis; 2022; 17():165-180. PubMed ID: 35068929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal.
    Vanfleteren L; Fabbri LM; Papi A; Petruzzelli S; Celli B
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3971-3981. PubMed ID: 30587953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
    Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E
    Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials.
    Lai CC; Chen CH; Lin CYH; Wang CY; Wang YH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1539-1548. PubMed ID: 31371939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review.
    Langham S; Lewis J; Pooley N; Embleton N; Langham J; Han MK; Chalmers JD
    Respir Res; 2019 Nov; 20(1):242. PubMed ID: 31684965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.
    Mapel D; Laliberté F; Roberts MH; Sama SR; Sundaresan D; Pilon D; Lefebvre P; Duh MS; Patel J
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1825-1836. PubMed ID: 28684905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β
    Skolnik NS; Nguyen TS; Shrestha A; Ray R; Corbridge TC; Brunton SA
    Postgrad Med; 2020 Mar; 132(2):198-205. PubMed ID: 31900019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual LABA/LAMA Therapy versus LABA or LAMA Monotherapy for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis in Support of the American Thoracic Society Clinical Practice Guideline.
    Mammen MJ; Pai V; Aaron SD; Nici L; Alhazzani W; Alexander PE
    Ann Am Thorac Soc; 2020 Sep; 17(9):1133-1143. PubMed ID: 32530702
    [No Abstract]   [Full Text] [Related]  

  • 10. [The stepwise approach of COPD therapy].
    Watz H; Kirsten A; Greulich T
    Dtsch Med Wochenschr; 2019 Jan; 144(1):15-20. PubMed ID: 30602182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study.
    Worth H; Buhl R; Criée CP; Kardos P; Lossi NS; Vogelmeier CF
    Respir Med; 2017 Oct; 131():77-84. PubMed ID: 28947047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple Therapy in COPD: What We Know and What We Don't.
    Calverley PMA; Magnussen H; Miravitlles M; Wedzicha JA
    COPD; 2017 Dec; 14(6):648-662. PubMed ID: 29120273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.
    Suissa S; Dell'Aniello S; Ernst P
    Lancet Respir Med; 2018 Nov; 6(11):855-862. PubMed ID: 30343028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Bronchodilator in the Era of Triple Therapy.
    Papaioannou AI; Loukides S; Bakakos P; Kosmas EN; Rovina N; Steiropoulos P; Fouka E; Hillas G; Patentalakis G; Kouvela M; Tzanakis N
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2695-2705. PubMed ID: 33149567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual bronchodilation vs triple therapy in the "real-life" COPD DACCORD study.
    Buhl R; Criée CP; Kardos P; Vogelmeier CF; Kostikas K; Lossi NS; Worth H
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2557-2568. PubMed ID: 30197512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.
    Nici L; Mammen MJ; Charbek E; Alexander PE; Au DH; Boyd CM; Criner GJ; Donaldson GC; Dreher M; Fan VS; Gershon AS; Han MK; Krishnan JA; Martinez FJ; Meek PM; Morgan M; Polkey MI; Puhan MA; Sadatsafavi M; Sin DD; Washko GR; Wedzicha JA; Aaron SD
    Am J Respir Crit Care Med; 2020 May; 201(9):e56-e69. PubMed ID: 32283960
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment Paradigm.
    Wilkie M; Finch S; Schembri S
    COPD; 2015; 12(5):582-90. PubMed ID: 25774769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic obstructive pulmonary disease: the right treatment for the right patient].
    Olschewski H; Buhl R; Funk GC; Valipour A; Vogelmeier CF
    Internist (Berl); 2021 Jun; 62(6):679-685. PubMed ID: 33860810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice.
    Suissa S; Dell'Aniello S; Ernst P
    Chest; 2020 Apr; 157(4):846-855. PubMed ID: 31759966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current appraisal of single inhaler triple therapy in COPD.
    Lipworth B; Kuo CR; Jabbal S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3003-3009. PubMed ID: 30319248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.